2023-07-10 00:58:17
Doctor Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO), at a press conference on June 5, 2012 announced the transport until 2025 of 18,000 doses of RTS, S malaria vaccines from the British pharmaceutical group GSK to 12 countries in 2 of Africa including Benin.
Bidossessi WANOU
After being administered in the pilot phase to more than 1.7 million children in Ghana, Kenya and Malawi, the antimalarial vaccine from the British pharmaceutical group GSK will be made available to twelve African countries. A total of 18 million doses of this vaccine, the very first is announced for the benefit of Benin, Burkina Faso, Burundi, Cameroon, the Democratic Republic of Congo, Liberia, Niger, Sierra Leone and Uganda. This is a wish carried by several people, especially on the continent. For good reason, “malaria remains one of the most deadly diseases in Africa, where it kills nearly half a million children under the age of 5 each year”, declared Doctor Tedros Adhanom Ghebreyesus, Director General WHO, at a press conference. In 2021, 96% of global malaria deaths occurred in Africa, the same year WHO counted 619,000 people worldwide. According to the DG/WHO, “It (the NDLR vaccine) has proven to be safe and effective, resulting in a substantial reduction in severe forms of malaria and a drop in child deaths”. About thirty African countries have come forward to receive doses. The first doses are expected for the last quarter of 2023, to be deployed in early 2024. But this will not be the only one. Already, a second antimalarial vaccine, R21/Matrix-M developed by the University of Oxford and produced by the Serum Institute in India (SII), “is under review for prequalification” by the WHO. It is about ensuring that health products for supply to low-income countries are safe and effective. And to the Director of the Department of Immunization and Vaccines at WHO, Kate O’Brien, to continue: “It is very important to remember that almost every minute a child dies from malaria, and the introduction of the malaria vaccine is a significant step forward”. This first vaccine “is a step in the right direction, and it foreshadows the millions of doses that will be distributed in the future”, she added. According to the WHO, UNICEF and Gavi, the annual global demand for malaria vaccines is expected to be 40 to 60 million doses by 2026, and to be between 80 and 100 million doses each year by 2030.
184 Total Views, 3 Views Today
Q. A.
juillet 9, 2023
#million #doses #vaccine #Benin #countries